News

17Jun, 2019

CIRCULOGENE – Subcontractor to U.S. Department of Defense Research Award – to Develop Liquid Biopsy Markers for Traumatic Brain Injury

$1.5 Million grant to The Geneva Foundation will use CIRCULOGENE’s liquid biopsy to quickly ID and accurately quantify organ-specific injury markers for improved treatment and survival in severely wounded military and civilian personnel. BIRMINGHAM, Ala.--(BUSINESS [...]

25Mar, 2019

CIRCULOGENE’s Precision Genomic Profiling Technology Featured in Three AACR 2019 Abstracts

Posters present data on utility of cfDNA for patient mutation load in NSCLC; cfRNA PD-L1 + MSI single-blood-tube testing; and innovative salvage of buccal NGS testing BIRMINGHAM, Ala.--(BUSINESS WIRE)-- CIRCULOGENE, advancing precision medicine through personalized [...]

19Feb, 2019

CIRCULOGENE Names Anthony L. Schmidt, M.D., as Medical Director

CIRCULOGENE Names Anthony L. Schmidt, M.D., as Medical Director BIRMINGHAM, Ala. – CIRCULOGENE, advancing precision medicine through molecular genetics testing, has named Anthony L. Schmidt, M.D., F.A.C.P., as Medical Director. Dr. Schmidt will lead the [...]